Perivascular adipose tissue inflammation in vascular disease

British Journal of Pharmacology

Volumn 174, Issue 20, 2017, Pages 3496-3513

  Nosalski, Ryszard ^a,b   Guzik, Tomasz J ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; FRACTALKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 17; INTERLEUKIN 17C; INTERLEUKIN 1BETA; INTERLEUKIN 23P19; INTERLEUKIN 6; L SELECTIN; LEPTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; RANTES; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RESISTIN; TUMOR NECROSIS FACTOR; UNCOUPLING PROTEIN 1; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1; CYTOKINE;

ABDOMINAL AORTIC ANEURYSM; ATHEROSCLEROSIS; B LYMPHOCYTE; BROWN ADIPOSE TISSUE; CELL FUNCTION; CELL INFILTRATION; CYTOKINE PRODUCTION; DENDRITIC CELL; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HYPERTENSION; INFLAMMATION; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; OXIDATIVE STRESS; PERIVASCULAR ADIPOSE TISSUE; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE CELL; WHITE ADIPOSE TISSUE; ADIPOSE TISSUE; ANIMAL; BLOOD VESSEL; IMMUNOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADIPOSE TISSUE; ANIMALS; BLOOD VESSELS; CYTOKINES; HUMANS; INFLAMMATION; VASCULAR DISEASES;

EID: 85012110591     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13705     Document Type: Review

References (195)

1. Akhavanpoor M, Wangler S, Gleissner CA, Korosoglou G, Katus HA, Erbel C (2014). Adventitial inflammation and its interaction with intimal atherosclerotic lesions. Front Physiol 5: 296.
2. Alexander SPH, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E et al. (2015a). The Concise Guide to PHARMACOLOGY 2015/16: Overview. Br J Pharmacol 172: 5729–5143.
3. Alexander SPH, Davenport AP, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015b). The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. Br J Pharmacol 172: 5744–5869.
4. Alexander SPH, Cidlowski JA, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015c). The Concise Guide to PHARMACOLOGY 2015/16: Nuclear hormone receptors. Br J Pharmacol 172: 5956–5978.
5. Alexander SPH, Fabbro D, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015d). The Concise Guide to PHARMACOLOGY 2015/16: Catalytic receptors. Br J Pharmacol 172: 5979–6023.
6. Alexander SPH, Fabbro D, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015e). The Concise Guide to PHARMACOLOGY 2015/16: Enzymes. Br J Pharmacol 172: 6024–6109.
7. Almabrouk TA, Ewart MA, Salt IP, Kennedy S (2014). Perivascular fat, AMP-activated protein kinase and vascular diseases. Br J Pharmacol 171: 595–617.
8. Almabrouk TA, Ugusman AB, Katwan OJ, Salt IP, Kennedy S (2017). Deletion of AMPKa1 attenuates the anticontractile effect of perivascular adipose tissue (PVAT) and reduces adiponectin release. Br J Pharmacol 174: 3398–3410.
9. Antonelli A, Fallahi P, Rotondi M, Ferrari SM, Romagnani P, Ghiadoni L et al. (2008). High serum levels of CXC chemokine ligand 10 in untreated essential hypertension. J Hum Hypertens 22: 579–581.
10. Antonopoulos AS, Margaritis M, Coutinho P, Shirodaria C, Psarros C, Herdman L et al. (2015). Adiponectin as a link between type 2 diabetes and vascular NADPH oxidase activity in the human arterial wall: the regulatory role of perivascular adipose tissue. Diabetes 64: 2207–2219.
11. Antonopoulos AS, Margaritis M, Verheule S, Recalde A, Sanna F, Herdman L et al. (2016). mutual regulation of epicardial adipose tissue and myocardial redox state by PPAR-gamma/adiponectin signalling. Circ Res 118: 842–855.
12. Asano K, Takahashi N, Ushiki M, Monya M, Aihara F, Kuboki E et al. (2015). Intestinal CD169(+) macrophages initiate mucosal inflammation by secreting CCL8 that recruits inflammatory monocytes. Nat Commun 6: 7802.
13. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M et al. (2006). Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235–238.
14. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A (2005). Resistin, an adipokine with potent proinflammatory properties. J Immunol 174: 5789–5795.
15. Bondar C, Araya RE, Guzman L, Rua EC, Chopita N, Chirdo FG (2014). Role of CXCR3/CXCL10 axis in immune cell recruitment into the small intestine in celiac disease. PLoS One 9: e89068.
16. Bot I, de Jager SC, Zernecke A, Lindstedt KA, van Berkel TJ, Weber C et al. (2007). Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice. Circulation 115: 2516–2525.
17. Broere F, Apasov SG, Sitkovsky MV, van Eden W (2011). A2 T cell subsets and T cell-mediated immunity. 15–27.
18. Bromley SK, Thomas SY, Luster AD (2005). Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat Immunol 6: 895–901.
19. Brown NK, Zhou Z, Zhang J, Zeng R, Wu J, Eitzman DT et al. (2014). Perivascular adipose tissue in vascular function and disease: a review of current research and animal models. Arterioscler Thromb Vasc Biol 34: 1621–1630.
20. Butcher MJ, Waseem TC, Galkina EV (2016). Smooth muscle cell-derived interleukin-17C plays an atherogenic role via the recruitment of proinflammatory interleukin-17A+ T cells to the aorta. Arterioscler Thromb Vasc Biol 36: 1496–1506.
21. Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C et al. (2005). Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54: 2277–2286.
22. Carnevale D, Pallante F, Fardella V, Fardella S, Iacobucci R, Federici M et al. (2014). The angiogenic factor PlGF mediates a neuroimmune interaction in the spleen to allow the onset of hypertension. Immunity 41: 737–752.
23. Carnevale D, Perrotta M, Pallante F, Fardella V, Iacobucci R, Fardella S et al. (2016). A cholinergic–sympathetic pathway primes immunity in hypertension and mediates brain-to-spleen communication. Nat Commun 7: 13035.
24. Cedikova M, Kripnerová M, Dvorakova J, Pitule P, Grundmanova M, Babuska V et al. (2016). Mitochondria in white, brown, and beige adipocytes. Stem Cells Int 2016: 1–11.
25. Chan CT, Moore JP, Budzyn K, Guida E, Diep H, Vinh A et al. (2012). Reversal of vascular macrophage accumulation and hypertension by a CCR2 antagonist in deoxycorticosterone/salt-treated mice. Hypertension 60: 1207–1212.
26. Chan CT, Sobey CG, Lieu M, Ferens D, Kett MM, Diep H et al. (2015). Obligatory role for B cells in the development of angiotensin II-dependent hypertension. Hypertension 66: 1023–1033.
27. Chang L, Villacorta L, Li R, Hamblin M, Xu W, Dou C et al. (2012). Loss of perivascular adipose tissue on peroxisome proliferator-activated receptor-gamma deletion in smooth muscle cells impairs intravascular thermoregulation and enhances atherosclerosis. Circulation 126: 1067–1078.
28. Channon KM, Guzik TJ (2002). Mechanisms of superoxide production in human blood vessels: relationship to endothelial dysfunction, clinical and genetic risk factors. J Physiol Pharmacol 53: 515–524.
29. Charo IF, Taubman MB (2004). Chemokines in the pathogenesis of vascular disease. Circ Res 95: 858–866.
30. Chatterjee TK, Aronow BJ, Tong WS, Manka D, Tang Y, Bogdanov VY et al. (2013). Human coronary artery perivascular adipocytes overexpress genes responsible for regulating vascular morphology, inflammation, and hemostasis. Physiol Genomics 45: 697–709.
31. Chatterjee TK, Stoll LL, Denning GM, Harrelson A, Blomkalns AL, Idelman G et al. (2009). Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ Res 104: 541–549.
32. Chava KR, Karpurapu M, Wang D, Bhanoori M, Kundumani-Sridharan V, Zhang Q et al. (2009). CREB-mediated IL-6 expression is required for 15(S)-hydroxyeicosatetraenoic acid-induced vascular smooth muscle cell migration. Arterioscler Thromb Vasc Biol 29: 809–815.
33. Cheng KK, Lam KS, Wang Y, Huang Y, Carling D, Wu D et al. (2007). Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells. Diabetes 56: 1387–1394.
34. Chmielewski S, Olejnik A, Sikorski K, Pelisek J, Blaszczyk K, Aoqui C et al. (2014). STAT1-dependent signal integration between IFNgamma and TLR4 in vascular cells reflect pro-atherogenic responses in human atherosclerosis. PLoS One 9: e113318.
35. Chung HK, Lee IK, Kang H, Suh JM, Kim H, Park KC et al. (2002). Statin inhibits interferon-gamma-induced expression of intercellular adhesion molecule-1 (ICAM-1) in vascular endothelial and smooth muscle cells. Exp Mol Med 34: 451–461.
36. Clark RA (2015). Resident memory T cells in human health and disease. Sci Transl Med 7: 269rv261.
37. Clement M, Guedj K, Andreata F, Morvan M, Bey L, Khallou-Laschet J et al. (2015). Control of the T follicular helper-germinal center B-cell axis by CD8(+) regulatory T cells limits atherosclerosis and tertiary lymphoid organ development. Circulation 131: 560–570.
38. de Jager SC, Bongaerts BW, Weber M, Kraaijeveld AO, Rousch M, Dimmeler S et al. (2012). Chemokines CCL3/MIP1alpha, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes. PLoS One 7: e45804.
39. Ding Z, Mizeracki AM, Hu C, Mehta JL (2013). LOX-1 deletion and macrophage trafficking in atherosclerosis. Biochem Biophys Res Commun 440: 210–214.
40. Dobrian AD, Hatcher MA, Brotman JJ, Galkina EV, Taghavie-Moghadam P, Pei H et al. (2015). STAT4 contributes to adipose tissue inflammation and atherosclerosis. J Endocrinol 227: 13–24.
41. Drayton DL, Liao S, Mounzer RH, Ruddle NH (2006). Lymphoid organ development: from ontogeny to neogenesis. Nat Immunol 7: 344–353.
42. Ensan S, Li A, Besla R, Degousee N, Cosme J, Roufaiel M et al. (2016). Self-renewing resident arterial macrophages arise from embryonic CX3CR1(+) precursors and circulating monocytes immediately after birth. Nat Immunol 17: 159–168.
43. Even SE, Dulak-Lis MG, Touyz RM, Dinh Cat AN (2014). Crosstalk between adipose tissue and blood vessels in cardiometabolic syndrome: implication of steroid hormone receptors (MR/GR). Horm Mol Biol Clin Investig 19: 89–101.
44. Fasshauer M, Kralisch S, Klier M, Lossner U, Bluher M, Klein J et al. (2003). Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 301: 1045–1050.
45. Fesus G, Dubrovska G, Gorzelniak K, Kluge R, Huang Y, Luft FC et al. (2007). Adiponectin is a novel humoral vasodilator. Cardiovasc Res 75: 719–727.
46. Fitzgibbons TP, Kogan S, Aouadi M, Hendricks GM, Straubhaar J, Czech MP (2011). Similarity of mouse perivascular and brown adipose tissues and their resistance to diet-induced inflammation. Am J Physiol Heart Circ Physiol 301: H1425–H1437.
47. Folkesson M, Vorkapic E, Gulbins E, Japtok L, Kleuser B, Welander M et al. (2016). Inflammatory cells, ceramides, and expression of proteases in perivascular adipose tissue adjacent to human abdominal aortic aneurysms. J Vasc Surg. doi:10.1016/j.jvs.2015.12.056.
48. Galkina E, Kadl A, Sanders J, Varughese D, Sarembock IJ, Ley K (2006). Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J Exp Med 203: 1273–1282.
49. Galvez B, de Castro J, Herold D, Dubrovska G, Arribas S, Gonzalez MC et al. (2006). Perivascular adipose tissue and mesenteric vascular function in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 26: 1297–1302.
50. Galvez-Prieto B, Bolbrinker J, Stucchi P, de Las Heras AI, Merino B, Arribas S et al. (2008). Comparative expression analysis of the renin-angiotensin system components between white and brown perivascular adipose tissue. J Endocrinol 197: 55–64.
51. Gao YJ (2007). Dual modulation of vascular function by perivascular adipose tissue and its potential correlation with adiposity/lipoatrophy-related vascular dysfunction. Curr Pharm Des 13: 2185–2192.
52. Gao YJ, Lu C, Su LY, Sharma AM, Lee RM (2007). Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide. Br J Pharmacol 151: 323–331.
53. Gao YJ, Takemori K, Su LY, An WS, Lu C, Sharma AM et al. (2006). Perivascular adipose tissue promotes vasoconstriction: the role of superoxide anion. Cardiovasc Res 71: 363–373.
54. GeurtsvanKessel CH, Willart MA, Bergen IM, van Rijt LS, Muskens F, Elewaut D et al. (2009). Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J Exp Med 206: 2339–2349.
55. Gollasch M, Dubrovska G (2004). Paracrine role for periadventitial adipose tissue in the regulation of arterial tone. Trends Pharmacol Sci 25: 647–653.
56. Greif M, Becker A, von Ziegler F, Lebherz C, Lehrke M, Broedl UC et al. (2009). Pericardial adipose tissue determined by dual source CT is a risk factor for coronary atherosclerosis. Arterioscler Thromb Vasc Biol 29: 781–786.
57. Griffin GK, Newton G, Tarrio ML, Bu DX, Maganto-Garcia E, Azcutia V et al. (2012). IL-17 and TNF-alpha sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation. J Immunol 188: 6287–6299.
58. Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ (2004). Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 21: 589–601.
59. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S et al. (2007a). Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 204: 2449–2460.
60. Guzik TJ, Mangalat D, Korbut R (2006). Adipocytokines – novel link between inflammation and vascular function? J Physiol Pharmacol 57: 505–528.
61. Guzik TJ, Marvar PJ, Czesnikiewicz-Guzik M, Korbut R (2007b). Perivascular adipose tissue as a messenger of the brain-vessel axis: role in vascular inflammation and dysfunction. J Physiol Pharmacol 58: 591–610.
62. Guzik TJ, Mikolajczyk T (2014). In search of the T cell involved in hypertension and target organ damage. Hypertension 64: 224–226.
63. Guzik TJ, Olszanecki R, Sadowski J, Kapelak B, Rudzinski P, Jopek A et al. (2005). Superoxide dismutase activity and expression in human venous and arterial bypass graft vessels. J Physiol Pharmacol 56: 313–323.
64. Hansson GK, Hermansson A (2011). The immune system in atherosclerosis. Nat Immunol 12: 204–212.
65. Harms M, Seale P (2013). Brown and beige fat: development, function and therapeutic potential. Nat Med 19: 1252–1263.
66. Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR et al. (2011). Inflammation, immunity, and hypertension. Hypertension 57: 132–140.
67. Henrichot E, Juge-Aubry CE, Pernin A, Pache JC, Velebit V, Dayer JM et al. (2005). Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis? Arterioscler Thromb Vasc Biol 25: 2594–2599.
68. Hoch NE, Guzik TJ, Chen W, Deans T, Maalouf SA, Gratze P et al. (2009). Regulation of T-cell function by endogenously produced angiotensin II. Am J Physiol Regul Integr Comp Physiol 296: R208–R216.
69. Hot A, Lenief V, Miossec P (2012). Combination of IL-17 and TNFalpha induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells. Ann Rheum Dis 71: 768–776.
70. Hu D, Mohanta SK, Yin C, Peng L, Ma Z, Srikakulapu P et al. (2015). Artery tertiary lymphoid organs control aorta immunity and protect against atherosclerosis via vascular smooth muscle cell lymphotoxin beta receptors. Immunity 42: 1100–1115.
71. Ide N, Hirase T, Nishimoto-Hazuku A, Ikeda Y, Node K (2008). Angiotensin II increases expression of IP-10 and the renin–angiotensin system in endothelial cells. Hypertens Res 31: 1257–1267.
72. Ignacak A, Kasztelnik M, Sliwa T, Korbut RA, Rajda K, Guzik TJ (2012). Prolactin–not only lactotrophin. A “new” view of the “old” hormone. J Physiol Pharmacol 63: 435–443.
73. Itani HA, McMaster WG Jr, Saleh MA, Nazarewicz RR, Mikolajczyk TP, Kaszuba AM et al. (2016). Activation of human T cells in hypertension: studies of humanized mice and hypertensive humans. Hypertension 68: 123–132.
74. Iwai M, Tomono Y, Inaba S, Kanno H, Senba I, Mogi M et al. (2009). AT2 receptor deficiency attenuates adipocyte differentiation and decreases adipocyte number in atherosclerotic mice. Am J Hypertens 22: 784–791.
75. Jin W, Dong C (2013). IL-17 cytokines in immunity and inflammation. Emerg Microbes Infect 2: e60.
76. Junt T, Scandella E, Ludewig B (2008). Form follows function: lymphoid tissue microarchitecture in antimicrobial immune defence. Nat Rev Immunol 8: 764–775.
77. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R et al. (2006). MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116: 1494–1505.
78. Kasal DA, Barhoumi T, Li MW, Yamamoto N, Zdanovich E, Rehman A et al. (2012). T regulatory lymphocytes prevent aldosterone-induced vascular injury. Hypertension 59: 324–330.
79. Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR (2003). Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 309: 286–290.
80. Kassan M, Galan M, Partyka M, Trebak M, Matrougui K (2011). Interleukin-10 released by CD4(+)CD25(+) natural regulatory T cells improves microvascular endothelial function through inhibition of NADPH oxidase activity in hypertensive mice. Arterioscler Thromb Vasc Biol 31: 2534–2542.
81. Kennedy S, Wu J, Wadsworth RM, Lawrence CE, Maffia P (2013). Mast cells and vascular diseases. Pharmacol Ther 138: 53–65.
82. Ketonen J, Shi J, Martonen E, Mervaala E (2010). Periadventitial adipose tissue promotes endothelial dysfunction via oxidative stress in diet-induced obese C57Bl/6 mice. Circ J 74: 1479–1487.
83. Kirabo A, Fontana V, de Faria AP, Loperena R, Galindo CL, Wu J et al. (2014). DC isoketal-modified proteins activate T cells and promote hypertension. J Clin Invest 124: 4642–4656.
84. Knorr M, Munzel T, Wenzel P (2014). Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction. Front Physiol 5: 295.
85. Kolak M, Westerbacka J, Velagapudi VR, Wagsater D, Yetukuri L, Makkonen J et al. (2007). Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 56: 1960–1968.
86. Koltsova EK, Garcia Z, Chodaczek G, Landau M, McArdle S, Scott SR et al. (2012). Dynamic T cell–APC interactions sustain chronic inflammation in atherosclerosis. J Clin Invest 122: 3114–3126.
87. Konior A, Schramm A, Czesnikiewicz-Guzik M, Guzik TJ (2014). NADPH oxidases in vascular pathology. Antioxid Redox Signal 20: 2794–2814.
88. Kontoyiannis D, Kotlyarov A, Carballo E, Alexopoulou L, Blackshear PJ, Gaestel M et al. (2001). Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. EMBO J 20: 3760–3770.
89. Kossmann S, Schwenk M, Hausding M, Karbach SH, Schmidgen MI, Brandt M et al. (2013). Angiotensin II-induced vascular dysfunction depends on interferon-gamma-driven immune cell recruitment and mutual activation of monocytes and NK-cells. Arterioscler Thromb Vasc Biol 33: 1313–1319.
90. Kotsias F, Hoffmann E, Amigorena S, Savina A (2013). Reactive oxygen species production in the phagosome: impact on antigen presentation in dendritic cells. Antioxid Redox Signal 18: 714–729.
91. Krause P, Morris V, Greenbaum JA, Park Y, Bjoerheden U, Mikulski Z et al. (2015). IL-10-producing intestinal macrophages prevent excessive antibacterial innate immunity by limiting IL-23 synthesis. Nat Commun 6: 7055.
92. Krensky AM, Ahn YT (2007). Mechanisms of disease: regulation of RANTES (CCL5) in renal disease. Nat Clin Pract Nephrol 3: 164–170.
93. La Cava A, Matarese G (2004). The weight of leptin in immunity. Nat Rev Immunol 4: 371–379.
94. Landmesser U, Cai H, Dikalov S, McCann L, Hwang J, Jo H et al. (2002). Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension 40: 511–515.
95. Lehman SJ, Massaro JM, Schlett CL, O'Donnell CJ, Hoffmann U, Fox CS (2010). Peri-aortic fat, cardiovascular disease risk factors, and aortic calcification: the Framingham Heart Study. Atherosclerosis 210: 656–661.
96. Lohmann C, Schafer N, von Lukowicz T, Sokrates Stein MA, Boren J, Rutti S et al. (2009). Atherosclerotic mice exhibit systemic inflammation in periadventitial and visceral adipose tissue, liver, and pancreatic islets. Atherosclerosis 207: 360–367.
97. Lohn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM (2002). Periadventitial fat releases a vascular relaxing factor. FASEB J 16: 1057–1063.
98. Lucas AD, Bursill C, Guzik TJ, Sadowski J, Channon KM, Greaves DR (2003). Smooth muscle cells in human atherosclerotic plaques express the fractalkine receptor CX3CR1 and undergo chemotaxis to the CX3C chemokine fractalkine (CX3CL1). Circulation 108: 2498–2504.
99. Mackay LK, Rahimpour A, Ma JZ, Collins N, Stock AT, Hafon ML et al. (2013). The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin. Nat Immunol 14: 1294–1301.
100. Madhur MS, Funt SA, Li L, Vinh A, Chen W, Lob HE et al. (2011). Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol 31: 1565–1572.
101. Madhur MS, Lob HE, McCann LA, Iwakura Y, Blinder Y, Guzik TJ et al. (2010). Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction. Hypertension 55: 500–507.
102. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H et al. (2002). Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8: 731–737.
103. Mahabadi AA, Reinsch N, Lehmann N, Altenbernd J, Kalsch H, Seibel RM et al. (2010). Association of pericoronary fat volume with atherosclerotic plaque burden in the underlying coronary artery: a segment analysis. Atherosclerosis 211: 195–199.
104. Manea SA, Todirita A, Raicu M, Manea A (2014). C/EBP transcription factors regulate NADPH oxidase in human aortic smooth muscle cells. J Cell Mol Med 18: 1467–1477.
105. Manka D, Chatterjee TK, Stoll LL, Basford JE, Konaniah ES, Srinivasan R et al. (2014). Transplanted perivascular adipose tissue accelerates injury-induced neointimal hyperplasia: role of monocyte chemoattractant protein-1. Arterioscler Thromb Vasc Biol 34: 1723–1730.
106. Marko L, Kvakan H, Park JK, Qadri F, Spallek B, Binger KJ et al. (2012). Interferon-gamma signaling inhibition ameliorates angiotensin II-induced cardiac damage. Hypertension 60: 1430–1436.
107. Marques RE, Guabiraba R, Russo RC, Teixeira MM (2013). Targeting CCL5 in inflammation. Expert Opin Ther Targets 17: 1439–1460.
108. Marvar PJ, Thabet SR, Guzik TJ, Lob HE, McCann LA, Weyand C et al. (2010). Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ Res 107: 263–270.
109. Mateo T, Naim Abu Nabah Y, Abu Taha M, Mata M, Cerda-Nicolas M, Proudfoot AEI et al. (2006). Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines. J Immunol 176: 5577–5586.
110. Matrougui K, Abd Elmageed Z, Kassan M, Choi S, Nair D, Gonzalez-Villalobos RA et al. (2011). Natural regulatory T cells control coronary arteriolar endothelial dysfunction in hypertensive mice. Am J Pathol 178: 434–441.
111. Matsuno K, Yamada H, Iwata K, Jin D, Katsuyama M, Matsuki M et al. (2005). Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice. Circulation 112: 2677–2685.
112. Mattu HS, Randeva HS (2013). Role of adipokines in cardiovascular disease. J Endocrinol 216: T17–T36.
113. Matusik P, Guzik B, Weber C, Guzik TJ (2012). Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice? Thromb Haemost 108: 443–456.
114. McMaster WG, Kirabo A, Madhur MS, Harrison DG (2015). Inflammation, immunity, and hypertensive end-organ damage. Circ Res 116: 1022–1033.
115. Mendizabal Y, Llorens S, Nava E (2013). Hypertension in metabolic syndrome: vascular pathophysiology. Int J Hypertens 2013: 230868.
116. Miao CY, Li ZY (2012). The role of perivascular adipose tissue in vascular smooth muscle cell growth. Br J Pharmacol 165: 643–658.
117. Mikolajczyk TP, Nosalski R, Szczepaniak P, Budzyn K, Osmenda G, Skiba D et al. (2016). Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension. FASEB J 30: 1987–1999.
118. Moore JP, Vinh A, Tuck KL, Sakkal S, Krishnan SM, Chan CT et al. (2015). M2 macrophage accumulation in the aortic wall during angiotensin II infusion in mice is associated with fibrosis, elastin loss, and elevated blood pressure. Am J Physiol Heart Circ Physiol 309: H906–H917.
119. Moos MP, John N, Grabner R, Nossmann S, Gunther B, Vollandt R et al. (2005). The lamina adventitia is the major site of immune cell accumulation in standard chow-fed apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 25: 2386–2391.
120. Murray PJ, Wynn TA (2011). Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11: 723–737.
121. Neumann P, Gertzberg N, Johnson A (2004). TNF-alpha induces a decrease in eNOS promoter activity. Am J Physiol Lung Cell Mol Physiol 286: L452–L459.
122. Neyt K, Perros F, GeurtsvanKessel CH, Hammad H, Lambrecht BN (2012). Tertiary lymphoid organs in infection and autoimmunity. Trends Immunol 33: 297–305.
123. Nguyen Dinh Cat A, Touyz RM (2011). A new look at the renin-angiotensin system–focusing on the vascular system. Peptides 32: 2141–2150.
124. Nguyen H, Chiasson VL, Chatterjee P, Kopriva SE, Young KJ, Mitchell BM (2013). Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension. Cardiovasc Res 97: 696–704.
125. Noh M (2012). Interleukin-17A increases leptin production in human bone marrow mesenchymal stem cells. Biochem Pharmacol 83: 661–670.
126. Omar A, Chatterjee TK, Tang Y, Hui DY, Weintraub NL (2014). Proinflammatory phenotype of perivascular adipocytes. Arterioscler Thromb Vasc Biol 34: 1631–1636.
127. Orshal JM, Khalil RA (2004). Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxation and enhances contraction in systemic vessels of pregnant rats. Am J Physiol Regul Integr Comp Physiol 286: R1013–R1023.
128. Owens AP 3rd, Rateri DL, Howatt DA, Moore KJ, Tobias PS, Curtiss LK et al. (2011). MyD88 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation independent of signaling through toll-like receptors 2 and 4. Arterioscler Thromb Vasc Biol 31: 2813–2819.
129. Parker DC (1993). T cell-dependent B cell activation. Annu Rev Immunol 11: 331–360.
130. Pei H, Gu J, Thimmalapura PR, Mison A, Nadler JL (2006). Activation of the 12-lipoxygenase and signal transducer and activator of transcription pathway during neointima formation in a model of the metabolic syndrome. Am J Physiol Endocrinol Metab 290: E92–E102.
131. Perros F, Dorfmuller P, Montani D, Hammad H, Waelput W, Girerd B et al. (2012). Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 185: 311–321.
132. Pietrowski E, Bender B, Huppert J, White R, Luhmann HJ, Kuhlmann CR (2011). Pro-inflammatory effects of interleukin-17A on vascular smooth muscle cells involve NAD(P)H- oxidase derived reactive oxygen species. J Vasc Res 48: 52–58.
133. Podolec J, Kopec G, Niewiara L, Komar M, Guzik B, Bartus K et al. (2016). Chemokine RANTES is increased at early stages of coronary artery disease. J Physiol Pharmacol 67: 321–328.
134. Police SB, Thatcher SE, Charnigo R, Daugherty A, Cassis LA (2009). Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler Thromb Vasc Biol 29: 1458–1464.
135. Rangel-Moreno J, Carragher DM, de la Luz Garcia-Hernandez M, Hwang JY, Kusser K, Hartson L et al. (2011). The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat Immunol 12: 639–646.
136. Resop RS, Douaisi M, Craft J, Jachimowski LC, Blom B, Uittenbogaart CH (2016). Sphingosine-1-phosphate/sphingosine-1-phosphate receptor 1 signaling is required for migration of naive human T cells from the thymus to the periphery. J Allergy Clin Immunol 138: 551–557 e558.
137. Robbins CS, Hilgendorf I, Weber GF, Theurl I, Iwamoto Y, Figueiredo JL et al. (2013). Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med 19: 1166–1172.
138. Rosner D, Stoneman V, Littlewood T, McCarthy N, Figg N, Wang Y et al. (2006). Interferon-γ induces Fas trafficking and sensitization to apoptosis in vascular smooth muscle cells via a PI3K- and Akt-dependent mechanism. Am J Pathol 168: 2054–2063.
139. Roussel L, Houle F, Chan C, Yao Y, Berube J, Olivenstein R et al. (2010). IL-17 promotes p38 MAPK-dependent endothelial activation enhancing neutrophil recruitment to sites of inflammation. J Immunol 184: 4531–4537.
140. Ruddy MJ, Wong GC, Liu XK, Yamamoto H, Kasayama S, Kirkwood KL et al. (2004). Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem 279: 2559–2567.
141. Safa A, Rashidinejad HR, Khalili M, Dabiri S, Nemati M, Mohammadi MM et al. (2016). Higher circulating levels of chemokines CXCL10, CCL20 and CCL22 in patients with ischemic heart disease. Cytokine 83: 147–157.
142. Sagan A, Mrowiecki W, Mikolajczyk TP, Urbanski K, Siedlinski M, Nosalski R et al. (2012). Local inflammation is associated with aortic thrombus formation in abdominal aortic aneurysms. Relationship to clinical risk factors. Thromb Haemost 108: 812–823.
143. Sage AP, Mallat Z (2014). Multiple potential roles for B cells in atherosclerosis. Ann Med 46: 297–303.
144. Sage AP, Murphy D, Maffia P, Masters LM, Sabir SR, Baker LL et al. (2014). MHC class II-restricted antigen presentation by plasmacytoid dendritic cells drives proatherogenic T cell immunity. Circulation 130: 1363–1373.
145. Sakaguchi S, Miyara M, Costantino CM, Hafler DA (2010). FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10: 490–500.
146. Sakamoto S, Tsuruda T, Hatakeyama K, Imamura T, Asada Y, Kitamura K (2014). Impact of age-dependent adventitia inflammation on structural alteration of abdominal aorta in hyperlipidemic mice. PLoS One 9: e105739.
147. Saleh MA, McMaster WG, Wu J, Norlander AE, Funt SA, Thabet SR et al. (2015). Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation. J Clin Invest 125: 1189–1202.
148. Saraiva M, O'Garra A (2010). The regulation of IL-10 production by immune cells. Nat Rev Immunol 10: 170–181.
149. Schenkel JM, Fraser KA, Beura LK, Pauken KE, Vezys V, Masopust D (2014). T cell memory. Resident memory CD8 T cells trigger protective innate and adaptive immune responses. Science 346: 98–101.
150. Schmidt TS, McNeill E, Douglas G, Crabtree MJ, Hale AB, Khoo J et al. (2010). Tetrahydrobiopterin supplementation reduces atherosclerosis and vascular inflammation in apolipoprotein E-knockout mice. Clin Sci (Lond) 119: 131–142.
151. Schrader LI, Kinzenbaw DA, Johnson AW, Faraci FM, Didion SP (2007). IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy. Arterioscler Thromb Vasc Biol 27: 2576–2581.
152. Schramm A, Matusik P, Osmenda G, Guzik TJ (2012). Targeting NADPH oxidases in vascular pharmacology. Vascul Pharmacol 56: 216–231.
153. Shah D, Wanchu A, Bhatnagar A (2011). Interaction between oxidative stress and chemokines: possible pathogenic role in systemic lupus erythematosus and rheumatoid arthritis. Immunobiology 216: 1010–1017.
154. Shao J, Nangaku M, Miyata T, Inagi R, Yamada K, Kurokawa K et al. (2003). Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension 42: 31–38.
155. Shirai T, Hilhorst M, Harrison DG, Goronzy JJ, Weyand CM (2015). Macrophages in vascular inflammation–from atherosclerosis to vasculitis. Autoimmunity 48: 139–151.
156. Siegel-Axel DI, Haring HU (2016). Perivascular adipose tissue: an unique fat compartment relevant for the cardiometabolic syndrome. Rev Endocr Metab Disord 17: 51–60.
157. Skiba DS, Nosalski R, Mikolajczyk TP, Siedlinski M, Rios FJ, Montezano AC et al. (2016). Antiatherosclerotic effect of Ang- (1–7) non-peptide mimetic (AVE 0991) is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis. Br J Pharmacol. doi:10.1111/bph.13685.
158. Skurk T, Herder C, Kraft I, Muller-Scholze S, Hauner H, Kolb H (2005). Production and release of macrophage migration inhibitory factor from human adipocytes. Endocrinology 146: 1006–1011.
159. Skurk T, van Harmelen V, Hauner H (2004). Angiotensin II stimulates the release of interleukin-6 and interleukin-8 from cultured human adipocytes by activation of NF-kappaB. Arterioscler Thromb Vasc Biol 24: 1199–1203.
160. Slifka MK, Whitton JL (2000). Activated and memory CD8+ T cells can be distinguished by their cytokine profiles and phenotypic markers. J Immunol 164: 208–216.
161. Smith E, Prasad KM, Butcher M, Dobrian A, Kolls JK, Ley K et al. (2010). Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 121: 1746–1755.
162. Soltis EE, Cassis LA (1991). Influence of perivascular adipose tissue on rat aortic smooth muscle responsiveness. Clin Exp Hypertens A 13: 277–296.
163. Southan C, Sharman JL, Benson HE, Faccenda E, Pawson AJ, Alexander SP, et al. (2016) The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucl Acids Res 44:D1054-1068.
164. Spear R, Boytard L, Blervaque R, Chwastyniak M, Hot D, Vanhoutte J et al. (2015). Adventitial tertiary lymphoid organs as potential source of MicroRNA biomarkers for abdominal aortic aneurysm. Int J Mol Sci 16: 11276–11293.
165. Stoger JL, Gijbels MJ, van der Velden S, Manca M, van der Loos CM, Biessen EA et al. (2012). Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis 225: 461–468.
166. Strom AC, Cross AJ, Cole JE, Blair PA, Leib C, Goddard ME et al. (2015). B regulatory cells are increased in hypercholesterolaemic mice and protect from lesion development via IL-10. Thromb Haemost 114: 835–847.
167. Surmi BK, Hasty AH (2010). The role of chemokines in recruitment of immune cells to the artery wall and adipose tissue. Vascul Pharmacol 52: 27–36.
168. Szasz T, Bomfim GF, Webb RC (2013). The influence of perivascular adipose tissue on vascular homeostasis. Vasc Health Risk Manag 9: 105–116.
169. Takaoka M, Suzuki H, Shioda S, Sekikawa K, Saito Y, Nagai R et al. (2010). Endovascular injury induces rapid phenotypic changes in perivascular adipose tissue. Arterioscler Thromb Vasc Biol 30: 1576–1582.
170. Takemori K, Gao YJ, Ding L, Lu C, Su LY, An WS et al. (2007). Elevated blood pressure in transgenic lipoatrophic mice and altered vascular function. Hypertension 49: 365–372.
171. Tilg H, Moschen AR (2006). Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 6: 772–783.
172. Tomono Y, Iwai M, Inaba S, Mogi M, Horiuchi M (2008). Blockade of AT1 receptor improves adipocyte differentiation in atherosclerotic and diabetic models. Am J Hypertens 21: 206–212.
173. van der Vorst EP, Doring Y, Weber C (2015). Chemokines. Arterioscler Thromb Vasc Biol 35: e52–e56.
174. van Wanrooij EJ, de Jager SC, van Es T, de Vos P, Birch HL, Owen DA et al. (2008). CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 28: 251–257.
175. Veillard NR, Kwak B, Pelli G, Mulhaupt F, James RW, Proudfoot AE et al. (2004). Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Circ Res 94: 253–261.
176. Veillard NR, Steffens S, Pelli G, Lu B, Kwak BR, Gerard C et al. (2005). Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo. Circulation 112: 870–878.
177. Vinh A, Chen W, Blinder Y, Weiss D, Taylor WR, Goronzy JJ et al. (2010). Inhibition and genetic ablation of the B7/CD28 T-cell costimulation axis prevents experimental hypertension. Circulation 122: 2529–2537.
178. Wang P, Xu TY, Guan YF, Su DF, Fan GR, Miao CY (2009). Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide. Cardiovasc Res 81: 370–380.
179. Wang Y, Bai Y, Qin L, Zhang P, Yi T, Teesdale SA et al. (2007). Interferon-gamma induces human vascular smooth muscle cell proliferation and intimal expansion by phosphatidylinositol 3-kinase dependent mammalian target of rapamycin raptor complex 1 activation. Circ Res 101: 560–569.
180. Wang Y, Burns WR, Tang PC, Yi T, Schechner JS, Zerwes HG et al. (2004). Interferon-gamma plays a nonredundant role in mediating T cell-dependent outward vascular remodeling of allogeneic human coronary arteries. FASEB J 18: 606–608.
181. Wassmann S, Stumpf M, Strehlow K, Schmid A, Schieffer B, Bohm M et al. (2004). Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res 94: 534–541.
182. Weber C, Shantsila E, Hristov M, Caligiuri G, Guzik T, Heine GH et al. (2016). Role and analysis of monocyte subsets in cardiovascular disease. Joint consensus document of the European Society of Cardiology (ESC) Working Groups “Atherosclerosis & Vascular Biology” and “Thrombosis”. Thromb Haemost 116: 626–637.
183. Wei Z, Spizzo I, Diep H, Drummond GR, Widdop RE, Vinh A (2014). Differential phenotypes of tissue-infiltrating T cells during angiotensin II-induced hypertension in mice. PLoS One 9: e114895.
184. Wensveen FM, Jelencic V, Valentic S, Sestan M, Wensveen TT, Theurich S et al. (2015). NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat Immunol 16: 376–385.
185. Wenzel P, Knorr M, Kossmann S, Stratmann J, Hausding M, Schuhmacher S et al. (2011). Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction. Circulation 124: 1370–1381.
186. Woodward L, Akoumianakis I, Antoniades C (2016). Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease. Br J Pharmacol. doi:10.1111/bph.13619.
187. Wu H, Ghosh S, Perrard XD, Feng L, Garcia GE, Perrard JL et al. (2007). T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 115: 1029–1038.
188. Wu J, Grassia G, Cambrook H, Ialenti A, MacRitchie N, Carberry J et al. (2015). Perivascular mast cells regulate vein graft neointimal formation and remodeling. PeerJ 3: e1192.
189. Wu J, Saleh MA, Kirabo A, Itani HA, Montaniel KR, Xiao L et al. (2016). Immune activation caused by vascular oxidation promotes fibrosis and hypertension. J Clin Invest 126: 50–67.
190. Wu J, Thabet SR, Kirabo A, Trott DW, Saleh MA, Xiao L et al. (2014). Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase. Circ Res 114: 616–625.
191. Wynn TA, Chawla A, Pollard JW (2013). Macrophage biology in development, homeostasis and disease. Nature 496: 445–455.
192. Yadava K, Bollyky P, Lawson MA (2016). The formation and function of tertiary lymphoid follicles in chronic pulmonary inflammation. Immunology 149: 262–269.
193. Yamashita A, Shoji K, Tsuruda T, Furukoji E, Takahashi M, Nishihira K et al. (2008). Medial and adventitial macrophages are associated with expansive atherosclerotic remodeling in rabbit femoral artery. Histol Histopathol 23: 127–136.
194. Zhang X, Chen X, Song H, Chen HZ, Rovin BH (2005). Activation of the Nrf2/antioxidant response pathway increases IL-8 expression. Eur J Immunol 35: 3258–3267.
195. Zou L, Wang W, Liu S, Zhao X, Lyv Y, Du C et al. (2016). Spontaneous hypertension occurs with adipose tissue dysfunction in perilipin-1 null mice. Biochim Biophys Acta 1862: 182–191.